In this episode of The Ganjapreneur Podcast, host TG Branfalt speaks with Dr. Gil Fanciullo, a longtime physician specializing in pain management and palliative care, about his early experiences recommending cannabis to patients well before it was legally accepted. Drawing from decades in medicine, including his work at Dartmouth-Hitchcock Medical Center, Fanciullo reflects on the risks physicians once faced, the patient-driven origins of medical cannabis adoption, and how attitudes within the medical community have evolved over time.
This interview explores the gaps that still exist in cannabis research, the complexities of cannabinoids and the so-called “entourage effect,” and the role cannabis could play in reducing reliance on pharmaceuticals like opioids. Fanciullo also discusses physician education, regulatory barriers, and what federal rescheduling could mean for both medical practice and the broader cannabis industry. Listen to the full episode below, or wherever you get your podcasts!
Listen to the episode: Read the transcript:
TG Branfalt (00:06):
Hey there. I’m your host, TG Branfalt, and this is the Ganjapreneur.com podcast where we try to bring you actionable information and normalize cannabis through the stories of entrepreneurs, activists, and industry stakeholders. Today, I am joined by Dr. Gil Fanciullo. He’s Professor Emeritus Dartmouth Medical
